You are here: Industry Insights > COMIRNATY

News List

Pfizer, BioNTech to Supply EU with Additional COMIRNATY Doses contractpharma
May 21, 2021
Pfizer and BioNTech SE entered a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the EU, with an option for the EC to request up to an additional 900 million doses.
Highlights of the May 2021 Pharmacovigilance Risk Assessment Committee (PRAC) meeting europeanpharmaceuticalreview
May 11, 2021
In its May meeting, the EMA’s drug safety committee (PRAC) concluded two safety signal reviews for COVID-19 vaccines and began several more.
Paediatric and adolescent COVID-19 vaccines update europeanpharmaceuticalreview
May 07, 2021
The EMA is evaluating whether to lower the age at which Comirnaty can be administered and Novavax has begun testing its COVID-19 vaccine in paediatric patients.
Pfizer, BioNTech seek CMA expansion for Covid-19 vaccine in EU pharmaceutical-technology
May 06, 2021
Pfizer and BioNTech have submitted a request to the European Medicines Agency (EMA) to expand Conditional Marketing Authorization (CMA) of their Covid-19 vaccine, COMIRNATY (BNT162b2), in the European Union (EU) for use in adolescents aged 12 to 15 years.
Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU contractpharma
April 20, 2021
EU orders 100 million additional doses of COMIRNATY, bringing total doses to 600 million for 27 EU member states.
Pfizer/BioNTech’s vaccine to touch sales of $24.8 billion by 2021: GlobalData expresspharma
April 15, 2021
Pfizer/BioNTech’s Comirnaty (tozinameran) is forecast to have peak sales of $24.8bn by 2021, which is only its second year on the market. This is a 20 per cent increase over Humira’s peak sales of $20.5 billion, suggesting that Comirnaty could be the ...
Pfizer, BioNTech to Supply EU with 200 Million Additional Doses of COMIRNATY americanpharmaceuticalreview
February 20, 2021
Pfizer and BioNTech announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states.
250mn Europeans to be vaccinated with COMIRNATY® by the end of 2021 europeanpharmaceuticalreview
February 19, 2021
Pfizer and BioNTech have agreed to supply the European Union with 200 million additional doses of COMIRNATY in 2021, making the total 500 million doses.
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong, S.A.R., China for COVID-19 Vaccine prnewswire
January 26, 2021
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong, S.A.R., China Special Administrative Region of the PRC, the COVID-19 vaccine COMIRNATY® (also known as BNT162b2, Chine
Pfizer, BioNTech to Supply the EU with 100 mn additional COVID-19 vaccine doses expresspharma
December 31, 2020
Total doses ordered reaches 300 million for 27 EU member states, all 300 million doses expected to be delivered in 2020 and 2021.

Previous page 1 2 3 Next page